• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT SOFAMOR DANEK PUERTO RICO MFG ENTERRA; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT SOFAMOR DANEK PUERTO RICO MFG ENTERRA; INTESTINAL STIMULATOR Back to Search Results
Model Number 7425G
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Chest Pain (1776); Dehydration (1807); Diarrhea (1811); Dyspnea (1816); Sepsis (2067); Dysphasia (2195); Urinary Frequency (2275); Malaise (2359); Lethargy (2560); Test Result (2695); No Code Available (3191)
Event Date 12/12/2001
Event Type  Injury  
Event Description
It was reported that the patient became ill with ¿profound¿ diarrhea and dehydration, noting that the diarrhea was ¿not new.¿ the patient improved after he was given intravenous (iv) fluids, but then worsened again that night, becoming more lethargic, having more excessive urination and diarrhea, and experiencing chest pain that was ¿mildly pleuritic¿ in nature.The patient was admitted to the hospital.Intermittent abdominal distress, slurred speech, and dyspnea were also noted.Non-device related symptoms included an upper respiratory infection or sinusitis in which cultures were taken, hyperglycemia due to underlying diabetes, chronic leg pain, decreased vision and cataracts, skin lesions and infections including diagnosed scabies, and puncture of lungs as a result of central line placement.Laboratory results showed ¿dramatic abnormalities¿ in his chemistries with serum glucose of approximately 1100, serum sodium of 114, ph of 7.349, dry mucous membranes, and white blood cell count at 16,000.Sepsis and hyponatremia were suspected, but physical exam did not show any obvious source of sepsis.The patient received medication included zithromax, intravenous (iv) fluids, iv insulin, and empirirc antibiotic coverage.Surgery was not performed.It was noted that the event ended on (b)(6) 2001 where the patient recovered from event with therapeutic action.Not clear of medical status prior to event.Further follow-up is being conducted to obtain this information.If additional information is received, a follow-up report will be sent.
 
Manufacturer Narrative
Product id neu_unknown_lead, serial# (b)(4), implanted: 2001 (b)(6); product type lead product id neu_unknown_lead, serial# (b)(4), implanted: 2001 (b)(6); product type lead (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERRA
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MDT SOFAMOR DANEK PUERTO RICO MFG
barrio marianna rd 909, km0.4
humacao PR 00792
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer Contact
diane wolf
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263987
MDR Report Key4064430
MDR Text Key4736610
Report Number6000032-2014-00184
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H990014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/23/2002
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/14/2002
Device Model Number7425G
Device Catalogue Number7425G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/23/2002
Date Device Manufactured05/23/2001
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age00022 YR
-
-